Concepedia

Jingjia Cao

JC

Statistics

Publications

3

Citations

58

H-Index

3

Active since

2021

Affiliations

Second Hospital of Shandong University(Current)

Shandong University

Jingjia Cao is an author at Second Hospital of Shandong University specializing in oncology, thyroid cancer genetics, and thyroid endocrinology.

ORCID

Publications per year

2021–2022

3

Publications

3

The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer

Jingjia Cao, Xiaolu Zhu, Yaru Sun et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 37 citations

, , +17

A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients

Juan Xiao, Canhua Yun, Jingjia Cao et al. · Scientific Reports · 2021 · 11 citations · Full text

, , +16

Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine

Canhua Yun, Juan Xiao, Jingjia Cao et al. · Cancer Medicine · 2021 · 10 citations · Full text

, , +17

1–3 of 3